Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.82 INR | -0.73% |
|
-2.35% | -19.97% |
May. 30 | Natural Biocon Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
Apr. 30 | Natural Biocon (India) CFO Passes Away | MT |
Valuation
Fiscal Period: March | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 177.5 | 102.8 | 52.77 |
Enterprise Value (EV) 1 | 180.7 | 102.4 | 50.3 |
P/E ratio | 6,458 x | 156 x | 29.5 x |
Yield | - | - | - |
Capitalization / Revenue | 135 x | 21.3 x | 4.21 x |
EV / Revenue | 137 x | 21.3 x | 4.01 x |
EV / EBITDA | - | - | - |
EV / FCF | 214,681,651 x | 9,192,252 x | 27,011,299 x |
FCF Yield | 0% | 0% | 0% |
Price to Book | 1.48 x | 0.85 x | 0.43 x |
Nbr of stocks (in thousands) | 11,373 | 11,373 | 11,373 |
Reference price 2 | 15.61 | 9.040 | 4.640 |
Announcement Date | 9/1/21 | 9/4/22 | 8/26/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 10.43 | 4.489 | - | 1.319 | 4.818 | 12.54 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | 10.01 | 1.12 | -0.316 | 0.0426 | 0.8873 | 2.482 |
Operating Margin | 95.96% | 24.95% | - | 3.23% | 18.41% | 19.79% |
Earnings before Tax (EBT) 1 | 10.01 | 1.21 | -0.3168 | 0.0367 | 0.8787 | 2.47 |
Net income 1 | 7.006 | 0.7261 | -0.3168 | 0.0275 | 0.659 | 1.791 |
Net margin | 67.19% | 16.17% | - | 2.08% | 13.68% | 14.28% |
EPS 2 | 0.6160 | 0.0600 | -0.0300 | 0.002417 | 0.0579 | 0.1575 |
Free Cash Flow | - | 0.6845 | -1.548 | 0.8418 | 11.14 | 1.862 |
FCF margin | - | 15.25% | - | 63.81% | 231.3% | 14.85% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | 94.28% | - | 3,061.35% | 1,691.14% | 103.98% |
Dividend per Share | - | 0.0500 | - | - | - | - |
Announcement Date | 5/18/20 | 5/18/20 | 9/21/20 | 9/1/21 | 9/4/22 | 8/26/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 7.95 | 6.42 | 3.18 | - | - |
Net Cash position 1 | 1.33 | - | - | - | 0.36 | 2.47 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | 0.68 | -1.55 | 0.84 | 11.1 | 1.86 |
ROE (net income / shareholders' equity) | - | 0.6% | -0.26% | 0.02% | 0.55% | 1.48% |
ROA (Net income/ Total Assets) | - | 0.55% | -0.15% | 0.02% | 0.45% | 1.2% |
Assets 1 | - | 132.1 | 206.4 | 129.7 | 146.6 | 149 |
Book Value Per Share 2 | 10.60 | 10.60 | 10.50 | 10.50 | 10.60 | 10.80 |
Cash Flow per Share 2 | 0.1200 | 0.0200 | 0.0300 | 0.0300 | 0.1800 | 0.3500 |
Capex | - | - | - | - | 0.07 | - |
Capex / Sales | - | - | - | - | 1.43% | - |
Announcement Date | 5/18/20 | 5/18/20 | 9/21/20 | 9/1/21 | 9/4/22 | 8/26/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-19.97% | 1.48M | |
+9.08% | 35.56B | |
-.--% | 11.64B | |
+30.24% | 8.11B | |
+9.91% | 6.98B | |
-10.07% | 6.85B | |
-11.66% | 5.63B | |
-8.77% | 5.31B | |
+34.29% | 5.16B | |
-5.10% | 5.03B |
- Stock Market
- Equities
- 543207 Stock
- Financials Natural Biocon (India) Limited